A New Era for Alzheimer’s
Fresh approaches and hopeful clues in the search for novel therapies
Fresh approaches and hopeful clues in the search for novel therapies
Some nominally high-risk individuals may have a lower chance of developing dementia than once thought
A new era for Alzheimer’s and journalism in the time of coronavirus
It is time for a fresh approach to the illness
Alzheimer’s took my wife’s memory and her life and tortured our family. There was nothing we—or medicine—could do to stop it
Most autistic individuals want to and can make friends, though their relationships often have a distinctive quality
The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses
Such children’s neural circuits do not transition properly from an active state to a resting one
Particular antioxidants in fruits and vegetables may lower chances of getting the disease
It may open the door to new treatments and explain why previous ones failed
A complex natural signaling system could help address impulse-control disorders
Promoting “healthspan” involves exercise and games
The disease may begin in the womb and require treatment early in life
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price?
After a string of drug failures, researchers are looking beyond amyloid as a target
Growing evidence from mouse studies suggests that a healthy microbiome might improve poststroke outcomes
An ability to read and write, even with little or no schooling, could offer protection
The drug targets the connection between the brain and the microbiome
Slow-wave activity during dreamless slumber helps wash out neural detritus
A deficit arises in molecules needed for neurons to communicate efficiently
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account